A novel antibody-drug conjugate targeting SAIL for the treatment of hematologic malignancies.
Kim SY, Theunissen JW, Balibalos J, Liao-Chan S, Babcock MC, Wong T, Cairns B, Gonzalez D, van der Horst EH, Perez M, Levashova Z, Chinn L, D'Alessio JA, Flory M, Bermudez A, Jackson DY, Ha E, Monteon J, Bruhns MF, Chen G, Migone TS.
Kim SY, et al. Among authors: perez m.
Blood Cancer J. 2015 May 29;5(5):e316. doi: 10.1038/bcj.2015.39.
Blood Cancer J. 2015.
PMID: 26024286
Free PMC article.